title: Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
abstract: Although non-obese diabetic (NOD) mice spontaneously develop T cell autoimmunity, it is not clear whether this phenomenon results from a defect in tolerance to self-Ag. Furthermore, as autoimmunity has been postulated to result from T cell responses directed toward self-peptides that bind with low affinity to NOD I-A(g7) MHC class II molecules, it is important to determine whether the expression of such peptides induces tolerance. We have constructed NOD transgenic (Tg) mice expressing the Leishmania antigen receptor for C kinase (LACK) Ag in either the thymus or pancreatic beta cells. We identified LACK peptides that were the targets of T cells in LACK-immunized NOD mice while binding to I-A(g7) with low affinity. While CD4(+) T cells from NOD mice secreted IFN-gamma, IL-4, IL-5 and IL-10 in response to LACK, those from LACK-expressing Tg mice secreted reduced levels of cytokines. Experiments using peptide/MHC multimers showed that LACK-expressing Tg mice exhibited self-reactive CD4(+) T cells with impaired proliferation capabilities. Hence, even self-peptides that bind to I-A(g7) with low affinity can induce tolerance in NOD mice. This result is important in light of the commonly held hypothesis that T cells reacting to peptides that bind to MHC with low affinity escape tolerance induction and cause autoimmunity.
authors.affiliation: INSERM E0344, Université de Nice-Sophia Antipolis, Valbonne, France.
authors.forename: Walter G
authors.initials: WG
authors.lastname: Ferlin
authors.forename: Evelyne
authors.initials: E
authors.lastname: Mougneau
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Hugues
authors.forename: Heiner
authors.initials: H
authors.lastname: Appel
authors.forename: Mei-Huei
authors.initials: MH
authors.lastname: Jang
authors.forename: Julie
authors.initials: J
authors.lastname: Cazareth
authors.forename: Lucie
authors.initials: L
authors.lastname: Beaudoin
authors.forename: Corinne
authors.initials: C
authors.lastname: Schricke
authors.forename: Agnès
authors.initials: A
authors.lastname: Lehuen
authors.forename: Kai W
authors.initials: KW
authors.lastname: Wucherpfennig
authors.forename: Nicolas
authors.initials: N
authors.lastname: Glaichenhaus
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D001324:Autoantigens / Q000276:immunology*; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D000949:Histocompatibility Antigens Class II / Q000378:metabolism*; D007108:Immune Tolerance; D051379:Mice; D016688:Mice, Inbred NOD; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology; D015800:Protozoan Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000953:Antigens, Protozoan; D001324:Autoantigens; D016207:Cytokines; D000949:Histocompatibility Antigens Class II; C407099:I-A g7 antigen; D010455:Peptides; D015800:Protozoan Proteins; C093139:LACK antigen, Leishmania